Usynova Pharmaceuticals Ltd.
Clinical trials sponsored by Usynova Pharmaceuticals Ltd., explained in plain language.
-
New psoriasis pill shows promise in 12-Week trial
Disease control Recruiting nowThis study tests an experimental oral medication (TYK2 inhibitor) in 140 adults with moderate to severe plaque psoriasis. Participants receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug can reduce psoriasis severity by at least 75% compared to …
Phase: NA • Sponsor: Usynova Pharmaceuticals Ltd. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New psoriasis pill enters early human safety trials
Symptom relief Recruiting nowThis early-stage study tests a new tablet called UA026 in healthy volunteers and people with moderate to severe plaque psoriasis. The main goal is to check if the drug is safe and how the body processes it. Researchers will also see if food affects the drug's absorption. The stud…
Phase: PHASE1 • Sponsor: Usynova Pharmaceuticals Ltd. • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC